Filing Flows

Filing Flows › Intelligent Bio Solutions (INBS) › Q3 FY26

Intelligent Bio Solutions (INBS) Q3 FY26 earnings results (third quarter fiscal 2026)

10-Q filed May 13, 2026

Intelligent Bio Solutions (INBS) reported revenue of $1.1M for the third quarter fiscal 2026 (Q3 FY26), +18% from a year earlier and +18% from the quarter before. Operating margin was -277.8%, net loss $2.9M (270.5% of revenue).

Revenue$1.1M
Year over year+18%
Quarter over quarter+18%
Operating margin-277.8%
Net earnings−$2.9M

Intelligent Bio Solutions, Q3 FY26: revenue $1.1M (+18% year over year), operating margin -277.8%, net loss $2.9M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.

Q3 FY26AmountQ/QY/Y
Revenue$1.1M+18%+18%
Operating profit−$2.9M——
Net earnings−$2.9M——
Operating cash flow−$4.3M——

What changed

Revenue was $1.1M in Q3 FY26, up 18% year over year and up 18% from the previous quarter. Sales of goods - cartridges was the largest line at 66% of revenue. Sales of goods - cartridges added $262K year over year (up 59%), 165% of the total change. Sales of goods - readers declined 16%.

Gross margin was 50.5%, up 12.6 points from Q3 FY25. Operating costs exceeded revenue by $2.9M, an operating margin of -277.8%. Operating expenses grew 20% against revenue growth of 18%. The fastest-growing cost line was Other operating costs (+110%). The quarter ended with a net loss of $2.9M, wider than the previous quarter's $2.7M loss. Minority interests bore $7K of it: to shareholders the quarter was a loss of $2.9M.

Operating cash flow was −$4.3M. Non-cash charges added back $290K of depreciation and amortization and $24K of share-based compensation. Working capital and other items used $1.8M. Capital expenditures of −$13K exceeded it, leaving free cash flow of −$4.3M.

Questions

What was Intelligent Bio Solutions' revenue in the third quarter fiscal 2026?

Intelligent Bio Solutions (INBS) reported revenue of $1.1M for the third quarter fiscal 2026 (Q3 FY26), +18% from a year earlier and +18% from the quarter before.

Was Intelligent Bio Solutions profitable in the third quarter fiscal 2026?

Operating loss was $2.9M (-277.8% of revenue) and net loss $2.9M.

Open the interactive Sankey →

Source: Intelligent Bio Solutions 10-Q on SEC EDGAR.